Conjunctival Malt Lymphoma: A Case Report

Tuna S., Karacetin D., Basaran M., Agaoglu F., Dogan O., BÜYÜKBABANİ N.

ISTANBUL MEDICAL JOURNAL, cilt.10, sa.4, ss.198-201, 2009 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 4
  • Basım Tarihi: 2009
  • Dergi Adı: ISTANBUL MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.198-201
  • Anahtar Kelimeler: MALT (Mucosa Associated Lymphoid Tissue) lymphoma, Chemotherapy, Radiotherapy, HELICOBACTER-PYLORI INFECTION, B-CELL LYMPHOMA, BORRELIA-BURGDORFERI, CHLAMYDIA-PSITTACI, MARGINAL ZONE, THERAPY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Whilst the etiology of the MALT (Mucosa Associate Lymphoid Tissue) lymphoma is not perfectly clarified, the blamed mechanism is a mature B-cell lymphoproliferative processes. This process is considered to have developed in connection with chronic antigenic stimulation which belongs to the extranodal marginal zone B-cell non-hodgkin indolent lymphoma class. A majority of the MALT lymphoma appear in the gastrointestinal system yet they may appear in tissue and organs like orbita, conjunctiva, lacrimal gland, bladder, lung, dura, thyroid, breast, and skin. Generally they have slow course and favorable prognoses. Chemotherapy and radiotherapy treatment options might be used. In this article, we are reporting 43 year old, female conjunctival MALT lymphoma demonstrative case with clinic and pathological specifications.